mixing bpc 157 10mg BPC-157 ( ) BPC-157 · 10mg · Research

This dual-peptide preparation contains BPC-157 (Body Protective Compound-157) and TB-500 (Thymosin Beta-4 fragment), two compounds frequently co-investigated in tissue repair and cellular migration research models

The peptide's combined action on collagen production, inflammation reduction, and vascularization makes it a compound of strong interest for joint recovery research in models of chronic mobility impairment

Methods: Study design: Multicentre cluster RCT with included health economic and process evaluations Study setting: Ambulance services, local stroke units and CSCs in England Cluster randomisation: Ambulance stations or teams Intervention: Specialist pre-hospital redirection pathway involving semi-structured telephone communication of information from ambulance to CSC clinicians, who then recommend admission destination according to the likelihood of treatable LVO being present Control: Standard care Study population: All suspected and confirmed stroke in participating regions Participant enrolment: Waiver of consent Co-primary outcome: Thrombectomy rate and time to treatment Secondary outcomes: Key aspects of emergency care including time intervals and receipt of other treatments including thrombolysis Sample size: Powered on a primary analysis population(ischaemic stroke), 564 thrombectomy procedures will detect at least 30-minutes difference in time to treatment

Madan AK, Frantzides CT, Patsavas KL

Minor injuries that would linger for weeks resolve in days